
Exsure Secures ₹3 Crore Seed Funding from Unicorn India Ventures
Exsure, founded in 2021 by Swastika Paul and Abhishek Dutta, has secured ₹3 crore in seed funding from Unicorn India Ventures. The startup is pioneering a patented exosome-based drug delivery platform designed to minimize the side effects and toxicity associated with anti-cancer drugs, thereby improving patient outcomes. The funds will be utilized to complete non-clinical studies and support global expansion plans.